ations in protein expression might also arise from differences in DNA methylation in promoter regions. A loss of methylation in the vicinity of the myotonic dystrophy (DM) untranslated CTG repeat subsequent to EBV transformation of lymphocytes has been recently reported. 5 The authors raise the possibility that the detection of proteins with an expanded polyglutamine tract in schizophrenia patients might be an artefact caused by a loss of methylation near a long CAG repeat, and subsequent translation of this repeat into polyglutamines after lymphocyte transformation with EBV. 5 However, it is interesting that a strong band of approximately 50 kDa was also found to react with the antibody 1C2 in protein extracts from post-mortem human brains of a limited number of schizophrenia patients (A Sharp and CA Ross, personal communication). Whether this 50-kDa band correlates with the polyglutamine proteins previously detected in some schizophrenia cases 1,2 will be investigated. In addition, while DM involves a very unstable CTG repeat which lies in a very large unmethylated CpG island, 6 the CAG repeat which codes for an expanded polyglutamine tract found in schizophrenia is likely to be moderately enlarged. The vast majority of long and unstable CAG repeats previously detected in schizophrenia patients by using the Repeat Expansion Detection technique indeed corresponds to CAG repeat loci (Dir 1 and CTG18.1) which are also expanded in the normal population, and might not be involved in the disease. 7 Consistently, the detection of an expanded polyglutamine tract in GRAP does not correlate with Dir 1 and CTG18.1 sizes. 2 A critical objective to further study polyglutamine tracts in schizophrenia is to test larger and/or more diverse cohorts of patients and controls for the presence of an expanded polyglutamine tract. While polyglutamine tracts do not appear to be involved in bipolar disorder, 8 expansion of a polyglutamine tract in a protein of approximately 50 kDa has been detected with the antibody 1C2 in a small number of adult onset schizophrenia patients who belong to a large cohort comprising over 200 individuals (tested by the group of GA Rouleau, unpublished data). Since large cohorts would be best screened at the DNA level, an equally important objective being pursued is to identify the gene which codes for the protein with an expanded polyglutamine tract found in some schizophrenia patients. In this respect, it is useful to compare the proteins detected with the antibody 1C2 in the 50-60 kDa range in different studies of schizophrenia 1,2 for size and pI, ideally on the same electrophoretic gel. Preliminary results based on standard one-dimensional gel electrophoresis suggest that GRAP 2 and the protein detected in adult onset schizophrenia 1 migrate to the same position in the gel (unpublished data), and bidimensional gel electrophoresis will be performed to determine whether the two proteins are similar. Considering the diversity of CAG/CTG repeat features and dynamics in the human genome, it is expected that conducting detailed protein analysis in a series of patients and controls will efficiently determine Lack of association between schizophrenia and a CAG repeat polymorphism of the hSKCa3 gene in a North Eastern US sample SIR -The N-terminal coding sequence of hSKCa3, a gene encoding a small conductance calcium-activated potassium channel, includes a highly polymorphic polyglutamine (CAG) repeat sequence with potential functional implications. 1,2 An association study of 98 Caucasian patients with schizophrenia and 118 ethnically matched unrelated controls revealed a significant excess of longer CAG repeat alleles among the cases, when the cohort was dichotomized using modal allele length. 1, 3 Significant associations were also reported among UK Caucasians (377 subjects), 4 and Jewish cohorts (186 subjects). 5 In contrast, some non-significant studies of comparable size were reported. [6] [7] [8] Repeat length also appeared unrelated to gender or age at onset. 9 To guard against artifacts due to population sub-structure, family-based samples were analyzed using the Transmission Disequilibrium Test (TDT). Significant associations were not detected in six different family-based samples reported so far, [10] [11] [12] [13] [14] [15] compared with four out of seven studies with unrelated controls. Since the family-based samples were generally smaller than the samples with unrelated controls, larger cohorts are needed. Such samples are not currently available to any one investigator. Therefore, reports like the present may be required for meta analysis.
Clinical information was obtained using the Diagnostic Interview for Genetics Studies 16 and available hospital notes. Individuals with a consensus diagnosis of schizophrenia or schizoaffective disorder (DSM-IV criteria) were included if one or both parents were available (101 cases and 131 parents from 88 families: seven affected sib-pairs (ASPs) with one parent, six ASPs with both parents, 37 single cases with both parents and 38 cases with one parent). There were 69 Caucasian and 19 African-American families. All ASPs were included in the analysis. Twelve cases from this sample have been reported on earlier. 1 All participants provided written informed consent as required by the University of Pittsburgh Institutional Review Board. A PCR-based assay was used to establish genotypes. 1 The TDT, corrected for multiple comparisons was performed using the ETDT and the Monte Carlo ETDT computer programs. 17, 18 The Fisher exact test was used to compare the distribution of 'short' and 'long' alleles among the transmitted and non-transmitted categories.
TDT results may be biased if single parent families are used. Therefore, we discarded such families if the case had the same genotype as the parent or if he/she was homozygous. 19 Among 108 informative transmissions (including 77 transmissions from two-parent families), significant allele-wise (P = 0.093) or genotype-wise (P = 0.43) associations were not detected (Table 1) . For the entire data set, when the alleles were sub-divided by modal length (19 6  6  3  6  1 6  9  6  6  6  17  16  11  13  7  18  20  18  17  14  19  32  30  21  20  20  12  12  9  7  21  3  11  3  8  2 2  1  0  0  0  2 3  0  2  0  0  Total  108  108  77  77 Only informative transmissions are listed. The Extended Transmission Disequilibrium test was used. 17 There was no parent-of-origin effect among maternal or paternal transmissions (P = 0.11 and 0.7 respectively). Control allele frequencies, calculated from the nontransmitted parental alleles using the haplotype-based haplotype relative risk method, 20 were not significantly different from the published reports. The original report suggested a medium effect size. 1 The present sample, with 108 transmissions, has over 80% power to detect such an effect. 21 However, the power may be reduced if the effect size varies among African-Americans and Caucasians, the groups examined here.
In conclusion, we were unable to detect an association between schizophrenia and hsKCa3. Though our sample is among the largest reported to date, familybased samples may be less powerful than samples of equivalent size using unrelated controls. 22 Therefore, further studies are warranted to enable meta analysis. 23 
